Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Piro

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Drugs|June 1, 1995
The optimal management of hairy cell leukaemiaR Gollard, T C Lee, L D Piro, et al.
Blood|September 10, 1998
Long-term follow-up of patients with hairy cell leukemia after cladribine treatmentA Saven, C Burian, J A Koziol, et al.
The New England Journal of Medicine|April 19, 1990
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosineL D Piro, C J Carrera, D A Carson, et al.
The New England Journal of Medicine|September 2, 1993
2-Chlorodeoxyadenosine to treat refractory histiocytosis XA Saven, M L Figueroa, L D Piro, et al.
Blood|September 1, 1988
2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaL D Piro, C J Carrera, E Beutler, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1982
Normal cortical bone mass in patients after long term coumadin therapyL D Piro, M P Whyte, W A Murphy, et al.
Blood|November 15, 1994
Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycleM G Goodman, S B Wormsley, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemiaA Saven, R H Lemon, M Kosty, et al.
Cancer Treatment and Research|January 1, 1993
Hairy cell leukemia: new understanding of biology and treatmentA Saven, L D Piro, C J Carrera, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaA Saven, C J Carrera, D A Carson, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Drugs|June 1, 1995
The optimal management of hairy cell leukaemiaR Gollard, T C Lee, L D Piro, et al.
Blood|September 10, 1998
Long-term follow-up of patients with hairy cell leukemia after cladribine treatmentA Saven, C Burian, J A Koziol, et al.
The New England Journal of Medicine|April 19, 1990
Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosineL D Piro, C J Carrera, D A Carson, et al.
The New England Journal of Medicine|September 2, 1993
2-Chlorodeoxyadenosine to treat refractory histiocytosis XA Saven, M L Figueroa, L D Piro, et al.
Blood|September 1, 1988
2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaL D Piro, C J Carrera, E Beutler, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1982
Normal cortical bone mass in patients after long term coumadin therapyL D Piro, M P Whyte, W A Murphy, et al.
Blood|November 15, 1994
Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycleM G Goodman, S B Wormsley, J C Spinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemiaA Saven, R H Lemon, M Kosty, et al.
Cancer Treatment and Research|January 1, 1993
Hairy cell leukemia: new understanding of biology and treatmentA Saven, L D Piro, C J Carrera, et al.
Leukemia & Lymphoma|July 28, 2016
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic LeukemiaA Saven, C J Carrera, D A Carson, et al.
Pageof 5